These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33083892)

  • 1. Factors Associated with Cancer Screening Among Hopi Men.
    Batai K; Sanderson PR; Hsu CH; Joshweseoma L; Russell D; Joshweseoma L; Ojeda J; Burhansstipanov L; Brown SR; Ami D; Saboda K; Harris RB
    J Cancer Educ; 2022 Aug; 37(4):915-923. PubMed ID: 33083892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Body mass index and cancer screening in older American Indian and Alaska Native men.
    Muus KJ; Baker-Demaray T; McDonald LR; Ludtke RL; Allery AJ; Bogart TA; Goldberg J; Ramsey SD; Buchwald DS
    J Rural Health; 2009; 25(1):104-8. PubMed ID: 19166569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
    Sirovich BE; Schwartz LM; Woloshin S
    JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit.
    Hall HI; Van Den Eeden SK; Tolsma DD; Rardin K; Thompson T; Hughes Sinclair A; Madlon-Kay DJ; Nadel M
    Prev Med; 2004 Jul; 39(1):27-35. PubMed ID: 15207983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer Screening on the Hopi Reservation: A Model for Success in a Native American Community.
    Brown SR; Joshweseoma L; Saboda K; Sanderson P; Ami D; Harris R
    J Community Health; 2015 Dec; 40(6):1165-72. PubMed ID: 26091896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formative Assessment to Improve Cancer Screenings in American Indian Men: Native Patient Navigator and mHealth Texting.
    Batai K; Sanderson PR; Joshweseoma L; Burhansstipanov L; Russell D; Joshweseoma L; Hsu CH
    Int J Environ Res Public Health; 2022 May; 19(11):. PubMed ID: 35682130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implications of false-positive results for future cancer screenings.
    Taksler GB; Keating NL; Rothberg MB
    Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer screening in Queensland men.
    Carrière P; Baade P; Newman B; Aitken J; Janda M
    Med J Aust; 2007 Apr; 186(8):404-7. PubMed ID: 17437394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of cancer screening services in Greece and associated social factors: results from the nation-wide Hellas Health I survey.
    Dimitrakaki C; Boulamatsis D; Mariolis A; Kontodimopoulos N; Niakas D; Tountas Y
    Eur J Cancer Prev; 2009 Jun; 18(3):248-57. PubMed ID: 19491613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the management of positive fecal occult blood tests.
    Rao SK; Schilling TF; Sequist TD
    J Gen Intern Med; 2009 Mar; 24(3):356-60. PubMed ID: 19130147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in colonoscopy and fecal occult blood test use after the introduction of dual screening offers in Germany: Results from a large population-based study, 2003-2016.
    Chen C; Stock C; Jansen L; Chang-Claude J; Hoffmeister M; Brenner H
    Prev Med; 2019 Jun; 123():333-340. PubMed ID: 30946858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal trends and regional disparities in cancer screening utilization: an observational Swiss claims-based study.
    Bähler C; Brüngger B; Ulyte A; Schwenkglenks M; von Wyl V; Dressel H; Gruebner O; Wei W; Blozik E
    BMC Public Health; 2021 Jan; 21(1):23. PubMed ID: 33402140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies.
    Inadomi JM; Vijan S; Janz NK; Fagerlin A; Thomas JP; Lin YV; Muñoz R; Lau C; Somsouk M; El-Nachef N; Hayward RA
    Arch Intern Med; 2012 Apr; 172(7):575-82. PubMed ID: 22493463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening.
    Church TR; Yeazel MW; Jones RM; Kochevar LK; Watt GD; Mongin SJ; Cordes JE; Engelhard D
    J Natl Cancer Inst; 2004 May; 96(10):770-80. PubMed ID: 15150305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
    Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
    J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal cancer screening participation: comparisons with mammography and prostate-specific antigen screening.
    Lemon S; Zapka J; Puleo E; Luckmann R; Chasan-Taber L
    Am J Public Health; 2001 Aug; 91(8):1264-72. PubMed ID: 11499116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Colorectal Cancer Screening Among Adults in Zuni Pueblo: Factors Associated with FOBT and Colonoscopy Utilization.
    Edwardson N; Cartwright K; Sheche J; Pankratz VS; Kosich M; Kanda D; Leekity S; Mishra SI
    J Community Health; 2023 Aug; 48(4):565-575. PubMed ID: 36752868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is the patient activation measure associated with adherence to colonoscopy after a positive fecal occult blood test result?
    Azulay R; Valinsky L; Hershkowitz F; Magnezi R
    Isr J Health Policy Res; 2018 Dec; 7(1):74. PubMed ID: 30577883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Accuracy of screening for fecal occult blood on a single stool sample obtained by digital rectal examination: a comparison with recommended sampling practice.
    Collins JF; Lieberman DA; Durbin TE; Weiss DG;
    Ann Intern Med; 2005 Jan; 142(2):81-5. PubMed ID: 15657155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in colorectal cancer screening use after introduction of alternative screening offer in Germany: Prospective cohort study.
    Guo F; Chen C; Schöttker B; Holleczek B; Hoffmeister M; Brenner H
    Int J Cancer; 2020 May; 146(9):2423-2432. PubMed ID: 31291471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.